Affordable Access

Practical management of liver transplant recipients for hepatitis C.

Authors
  • Saab, S1
  • Busuttil, R W
  • 1 Division of Digestive Diseases, Department of Medicine, University of California, Los Angeles, USA. [email protected]
Type
Published Article
Journal
Minerva chirurgica
Publication Date
Aug 01, 2003
Volume
58
Issue
4
Pages
479–489
Identifiers
PMID: 14603160
Source
Medline
Language
English
License
Unknown

Abstract

Hepatitis C is one of the leading indications for liver transplantation. Recipients can expect at least a short-term survival equivalent to other indications for liver transplantation. However, the rates of cirrhosis and decompensation development is substantially faster than those rates seen in non-transplant setting. Advances in antiviral therapy are now associated with a sustained virological response of 20% with combination antiviral with interferon and ribavirin. Higher response rates are expected with utilizing pegylated interferon.

Report this publication

Statistics

Seen <100 times